Nib Holdings Limited (ASX: NHF)
Nib Holdings Limited
ASX:
NHF
Nib Holdings Ltd. engages in the provision of health and medical insurance. It operates through the following segments: Australian Residents Health Insurance, International (Inbound) Health Insurance, New Zealand Insurance, nib Travel, and nib Thrive. The Australian Residents Health Insurance segment offers product within the Australian private health insurance industry. The International (Inbound) Health Insurance segment includes health insurance products for international students and workers. The New Zealand Insurance segment consists of product for the New Zealand private health insurance industry. The nib Travel segment pertains to distribution of travel insurance products. The nib Thrive segment is involved in offering as a plan manager under the National Disability Insurance Scheme. The company was founded in 1952 and is headquartered in Newcastle, Australia.
Stock Performance Profile:
(Source: TradingView) One-Year Performance Profile of NHF compared to ASX 200 (XJO).
From the company reports:
FY24 Highlights:
Nib Holdings Limited (ASX: NHF) reported its financial results for the fiscal year ending June 30, 2024, demonstrating robust performance across key metrics.
Group revenue reached $3.3 billion, representing a 9.3% increase compared to FY23, while group claims rose by 6.7% to $2.5 billion. Net investment income contributed $61.7 million to pre-tax earnings, reflecting a 12.8% improvement year-over-year.
Net Profit After Tax (NPAT) surged to $181.6 million, marking a 67.4% increase, or 2.8% under the prior accounting standard (AASB1023). Since FY19, Group Underlying Operating Profit (UOP) has achieved a compound annual growth rate (CAGR) of 5.2%.
For FY24, UOP climbed to $257.5 million, reflecting a 77.3% increase under the updated accounting standard (AASB17), or 5.9% under AASB1023.
Historical Financial Snapshot:
(Data Source: TradingView. Graphic Source: Pristine Gaze)
The company demonstrates a consistently strong financial growth trajectory, with revenues increasing from $2.54 billion in 2020 to $3.41 billion in 2024. Despite annual fluctuations, net income has exhibited robust long-term growth, rising from $87 million in 2020 to $185 million in 2024. However, the second half of FY2024 saw a notable decline in earnings, with operating income and net income falling by 23% year-over-year to $113 million and $73 million, respectively. This decline was primarily attributed to a significant increase in long-term insurance reserve expenditures, which aligns with the company’s broader operational and revenue growth trends and expectations, reflecting prudent financial planning to support its sustained expansion.
Growth Catalyst:
(Graphic Source: Company Reports)
Nib has demonstrated substantial and innovative growth within Australia’s insurance sector, leveraging both organic and inorganic strategies to diversify its product offerings across multiple insurance verticals, including travel and health. The company has also expanded geographically, significantly increasing its presence in New Zealand. Its growing footprint in health insurance for both Australian residents and international customers presents a promising avenue for future scalability. Additionally, Nib’s innovative platforms, such as Honeysuckle Health and Midnight Health, enhance its ability to serve both customers and healthcare providers by delivering tailored treatment and healthcare solutions, including access to underserved populations in remote Australian regions. The Nib Thrive segment, which facilitates intermediary services between healthcare providers and over 40,000 NDIS participants, further highlights the company’s potential for long-term growth and market expansion.
Outlook:
(Graphic Source: Company Reports)
Nib has consistently outperformed industry growth rates over the past two decades, achieving a compound annual growth rate (CAGR) of 5.2% since 2001, more than double the industry average of 2.2%. While market expectations suggest a potential moderation in premium growth within the Australian insurance sector—following unprecedented increases in recent years driven by high inflation—the industry still holds the potential for double-digit premium growth during certain inflationary periods. Even as growth normalizes, the outlook remains strong, particularly for health insurance, which continues to be a critical necessity for a significant portion of the Australian population.
Risk Analysis:
Nib faces risks associated with regulatory changes in the health insurance sector, which could impact pricing, coverage, and profitability. Rising healthcare costs and claims inflation may pressure margins, particularly if premium adjustments are restricted. Competition from other insurers and evolving consumer preferences for coverage options pose market share challenges. Additionally, economic downturns could reduce policy uptake or retention rates, while cyber risks and data breaches could threaten customer trust and operational stability.
Technical Analysis:
(Graphic Source: TradingView) Nib Holdings Limited (ASX: NHF) Weekly Time-Frame (WTF) Chart.
Nib, despite its current downtrend, exhibits signs of a potential trend reversal. The stock is rebounding from its lower Bollinger Bands, suggesting a shift in momentum. Additionally, the nearest Fibonacci retracement level around $5.36 serves as a strong support, effectively limiting downside risk for investors. The stock’s Relative Strength Index (RSI) of 33, nearing oversold territory, further indicates the possibility of a rebound, reinforcing the potential for a recovery in the near term.
Analyst’s Take:
Nib holds a distinguished position within the Australian insurance industry, poised to benefit from the sector’s inherent stability, growth potential, and scalable earnings prospects. The company presents a compelling value proposition, with a robust financial growth trajectory yet trading at a relatively low P/E ratio of 14x, significantly below its historical average of approximately 30x and the industry average of around 25x. This notable undervaluation underscores an attractive entry point for investors. Additionally, Nib offers an appealing annual dividend yield exceeding 5%, providing shareholders with a lucrative opportunity for consistent income generation alongside potential capital appreciation.
As per Pristine Gaze, you may consider a “Buy” on “Nib Holdings Limited” at the closing price of “$5.51” (As of 22 January 2025).
*All currency figures are in Australian Dollars unless stated otherwise.
*All data sourced from Company Reports and TradingView.
Disclaimer
The reports provided by Pristine Gaze are designed to deliver general financial insights, including stock and sector market analysis and investment commentary. These reports aim to support informed decision-making but are strictly intended for informational purposes. They do not constitute personalized financial advice and should not be relied upon as such. The information provided does not take into account individual investment objectives, financial circumstances, or specific needs.
General Advice Warning
The insights and recommendations offered in Pristine Gaze reports are of a general nature and are not tailored to any individual investor’s circumstances. Investment decisions are highly personal and depend on many factors, including but not limited to financial goals, risk tolerance, and current financial standing. We strongly advise consulting a qualified financial advisor who can evaluate your unique situation and provide professional guidance tailored to your needs before acting on any information contained in these reports.
Past Performance
Historical data, including past performance metrics of securities or markets mentioned in these reports, should not be regarded as an accurate indicator of future results. The financial markets are subject to significant variability, and past success does not guarantee similar outcomes in the future. It is essential to recognize that external factors, including but not limited to economic conditions, regulatory changes, and market dynamics, can greatly influence future performance and results.
Forward-Looking Statements
Certain projections and forecasts presented in Pristine Gaze reports may include forward-looking statements based on assumptions and expectations about future market conditions. These statements are speculative and inherently uncertain, as they depend on variables that may not materialize as anticipated. Factors such as economic conditions, market trends, policy changes, and unforeseen events can significantly impact these projections. Investors should approach forward-looking statements with caution and recognize the associated risks.
Data Accuracy
All financial data, metrics, and projections contained in our reports are derived from publicly available company filings, credible industry reports, and verified sources. While Pristine Gaze endeavors to ensure the accuracy, timeliness, and reliability of the information provided, we cannot guarantee its completeness or precision. Market conditions and company policies may evolve, leading to changes in the relevance of the data presented. The content of our reports may be updated or modified without prior notice.
Technical Analysis
Reports may include discussions of technical indicators, such as Relative Strength Index (RSI), Bollinger Bands, or moving averages. These indicators are tools used to analyze market trends but are inherently speculative and subject to interpretation. They do not provide definitive predictions about future price movements and should not be relied upon as sole determinants of investment decisions. Investors should combine technical analysis with other forms of research and risk assessment.
Dividend Yield
References to dividend payments or yields are based on historical data and the current financial policies of the companies discussed. Dividends are not guaranteed and may fluctuate depending on the financial performance of the company, market conditions, and regulatory requirements. Investors should consider these variables and the potential for dividend changes when evaluating dividend-paying securities.
Liability Disclaimer
Pristine Gaze, along with its directors, employees, associates, and affiliates, assumes no responsibility or liability for any losses or damages incurred due to reliance on the information or recommendations contained in our reports. This disclaimer applies to all forms of losses, including but not limited to direct, indirect, incidental, or consequential losses. Investors are hereby advised to conduct their independent research and seek professional advice before making investment decisions.
Third-Party Data and Links
Some reports may reference external data, include hyperlinks to third-party websites, or incorporate information from other sources. While we aim to use credible and reliable references, Pristine Gaze does not endorse or take responsibility for the accuracy or reliability of external content. Users are advised to evaluate third-party information critically and acknowledge the risks of using such data.
Intellectual Property
All content within Pristine Gaze reports, including but not limited to text, graphics, designs, methodologies, and analyses, is the exclusive intellectual property of Pristine Gaze Pty Ltd. This content is protected under Australian and international copyright and trademark laws. Unauthorized reproduction, modification, or distribution of any part of the content without prior written consent from Pristine Gaze is strictly prohibited. Legal action may be pursued in the case of infringement.
Terms and Policies
For additional information regarding the terms and conditions of our services, our approach to data privacy, and the scope of our financial advice, please refer to our Terms and Conditions, Privacy Policy, and Financial Services Guide, which are available on our official website.
